Year To Quarter End Consolidated Statement Of Income

Solasia Pharma K.K. - Filing #7272454

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31
Year to quarter end consolidated statement of income
Statement of income
Net sales	—	—	—	—	—	316,000,000 JPY	—	—	—	—	617,000,000 JPY	—	—	—
Cost of sales	—	—	—	—	—	131,000,000 JPY	—	—	—	—	280,000,000 JPY	—	—	—
Gross profit (loss)	—	—	—	—	—	185,000,000 JPY	—	—	—	—	337,000,000 JPY	—	—	—
Selling, general and administrative expenses
Selling, general and administrative expenses	—	—	—	—	—	1,026,000,000 JPY	—	—	—	—	1,025,000,000 JPY	—	—	—
Operating profit (loss)	—	—	—	—	—	-840,000,000 JPY	—	—	—	—	-688,000,000 JPY	—	—	—
Non-operating income
Interest income	—	—	—	—	—	0 JPY	—	—	—	—	0 JPY	—	—	—
Non-operating income	—	—	—	—	—	0 JPY	—	—	—	—	10,000,000 JPY	—	—	—
Non-operating expenses
Interest expenses	—	—	—	—	—	0 JPY	—	—	—	—	0 JPY	—	—	—
Non-operating expenses	—	—	—	—	—	28,000,000 JPY	—	—	—	—	1,000,000 JPY	—	—	—
Ordinary profit (loss)	—	—	—	—	—	-869,000,000 JPY	—	—	—	—	-678,000,000 JPY	—	—	—
Profit (loss) before income taxes	—	—	—	—	—	-869,000,000 JPY	—	—	—	—	-678,000,000 JPY	—	—	—
Income taxes - current	—	—	—	—	—	0 JPY	—	—	—	—	0 JPY	—	—	—
Profit (loss)	-868,000,000 JPY	JPY	-868,000,000 JPY	JPY	JPY	-868,000,000 JPY	JPY	-679,000,000 JPY	JPY	JPY	-679,000,000 JPY	JPY	-679,000,000 JPY	JPY